| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |